Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
More 'bold decisions' and 'acceptability': Pharma industry-heads on their journey in building the industry
From the need to take bold decisions, including making an early entry into the biological products segment, to pushing for greater “acceptability” of Indian medicines in the domestic market - founders and promoter-family members from…
Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai
MUMBAI, India and NAPLES, Fla., Feb. 9, 2026 /CNW/ -- Made in India, written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India's pharma industry, the birth and evolution of Lupin (BSE: 500257) (NSE: LUPIN)…
Pharma leaders seek regulatory reform, faster trials to spur innovation
Speaking at a panel discussion on the past and future of Indian pharma at the launch of the book Made in India — The Story of Desh Bandhu Gupta, Lupin and Indian Pharma, industry stalwarts including Dilip Shanghvi, managing director of Sun…
Aurobindo Pharma board considers merger of subsidiaries
Last Updated: Feb 09 2026 | 7:51 PM IST Approves filing of scheme of merger of Auro Vaccines with Curateq Biologics The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved a proposal to file a scheme of amalgamation for…
Board of Aurobindo Pharma approves PPA with Garuda Renewables
Last Updated: Feb 09 2026 | 7:51 PM IST Also approves investment of Rs 66 cr in Garuda Renewables The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved to enter into a power purchase agreement with Garuda Renewables, to…
GLP-1 Feud: HIMS Fires Back At Novo Nordisk, Slams Lawsuit As 'Blatant Attack' By Big Pharma
Hims & Hers Health fired back at Novo Nordisk's lawsuit on X, calling it a 'blatant attack by a Danish company on millions of Americans' who depend on compounded medications to access personalized care. Once again, Big Pharma is weaponizing the US…
CM urged to lobby for setting up national pharma institute in capital
The Trivandrum Chamber of Commerce and Industry has requested Chief Minister Pinarayi Vijayan to take steps to establish the National Institute of Pharmaceutical Education and Research (NIPER) in Thiruvananthapuram. The Chamber noted that the State…
Aurobindo Pharma Q3 net up 7.6% to ₹910 cr. on higher Europe, ARV revenue
Generic drugmaker Aurobindo Pharma reported December quarter consolidated net profit increased 7.6% to ₹910 crore compared to the ₹846 crore a year earlier. The profit came on a more than 8% increase in revenue from operations to…
Aurobindo Pharma Q3FY26 results: Net profit rises 8% to ₹910 crore
Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to ₹910 crore for the December quarter, led by robust sales in Europe and the US. The Hyderabad-based drug major reported a net profit of…
Aurobindo Pharma Q3 PAT up by 7.6% at ₹910 crore
Aurobindo Pharma Ltd has posted a net profit of ₹910 crore for the quarter ended December 31, 2025, as against ₹846 crore in the same quarter last year, showing a growth of 7.6 per cent. The company's revenue stood at ₹8,646…
Black Swan Supply Chain: US Dependence on China for Pharma, Medical Supplies May Lead to Severe Interruptions
Even before a supply line interruption and lockdowns in China, hospitals and doctors nationwide in the U.S. are facing shortages of crucial lifesaving drugs, with 116 drugs currently running low, according to the Food and Drug Administration (FDA).
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
HERZLIYA, Israel and CALGARY, AB, Feb. 9, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ('Innocan' or the 'Company'), a pioneer in the pharmaceutical and biotechnology industries, proudly announces the publication…
3 Pharma stocks to watch: Will they turn healthy today?
Alembic Pharmaceuticals Ltd has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbidopa, Levodopa and Entacapone Tablets, 12.5 mg/50 mg/200 mg, 18.75 mg/75 mg/200 mg, 25…
Pre-check pilot to boost local pharma manufacturing in the US
The US Food and Drug Administration has begun accepting requests from those seeking to participate in the FDA PreCheck pilot programme. Designed to strengthen the domestic pharmaceutical supply chain by increasing regulatory predictability, the FDA…
Novartis begins construction of new research centre in San Diego, US
The new centre is a key pillar of the pharmaceutical group's planned $23 billion (CHF19 billion) investment in the US. The facility is designed to accelerate the discovery of breakthrough drugs and will become an integral part of Novartis's global…
Receive a Daily briefing on Pharma Industry News
Get Started